← Back to Search

Peer Wellness Enhancement for Mental Illness

N/A
Waitlist Available
Led By Chyrell D Bellamy, Ph.D.
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be CMHC enrolled patients in the Behavioral Health Homes Program over the age of 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 months
Awards & highlights

Study Summary

This trial will test a peer-led intervention to help people with serious mental illness live healthier lives by addressing social determinants of health.

Who is the study for?
This trial is for adults over 18 with serious mental illness (SMI) who are enrolled in the Behavioral Health Homes Program. It aims to help those facing early death due to untreated chronic medical conditions by improving overall health and wellness.Check my eligibility
What is being tested?
The study is testing 'WE Harambee', a peer-led intervention designed to enhance wellness among people with SMI, alongside enrollment in a Behavioral Health Home program. Its feasibility, acceptability, and preliminary effectiveness will be evaluated.See study design
What are the potential side effects?
Since this trial involves non-medical interventions focusing on social support and behavioral changes rather than drugs or medical procedures, specific side effects are not detailed but may include emotional discomfort or stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and enrolled in the Behavioral Health Homes Program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported barriers and facilitators to healthcare
Self-reported coping and problem solving
Self-reported empowerment
+6 more
Secondary outcome measures
Body mass index (BMI) level
Diastolic blood pressure
High-density lipoprotein (HDL) level
+14 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Peer Wellness Enhancement (WE Harambee)Experimental Treatment1 Intervention
This project employs a pragmatic, stepped wedge experimental design in which 60 BHH participants are randomly assigned to one of 3 waves of WE Harambee implementation (20 in each wave) during the 2 year study. Participants in this arm receive the WE Harambee Wellness Enhancement and are enrolled in a Behavioral Health Home. WE Harambee is a 6-month peer-delivered whole health intervention intended to address the 8 dimensions of wellness and the social determinants of health.
Group II: Behavioral Health Home enrollmentExperimental Treatment1 Intervention
In the stepped wedge experimental design, 40 participants at any time during the 2 year study are receiving only the Behavioral Health Home (BHH) intervention. The 2010 Patient Protection and Affordable Care Act (ACA) established a "health home" option under Medicaid that serves enrollees with chronic conditions including serious mental illness and chronic physical illness.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,047 Total Patients Enrolled
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,468 Total Patients Enrolled
Chyrell D Bellamy, Ph.D.Principal InvestigatorYale University

Media Library

Behavioral Health Home Enrollment Clinical Trial Eligibility Overview. Trial Name: NCT03673852 — N/A
Chronic Conditions Research Study Groups: Behavioral Health Home enrollment, Peer Wellness Enhancement (WE Harambee)
Chronic Conditions Clinical Trial 2023: Behavioral Health Home Enrollment Highlights & Side Effects. Trial Name: NCT03673852 — N/A
Behavioral Health Home Enrollment 2023 Treatment Timeline for Medical Study. Trial Name: NCT03673852 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently open for enrollment?

"The clinical trial's information hosted on the clinicaltrials.gov website indicates that it is not currently enrolling patients - this study was initially posted on December 6th 2018 and last updated February 15th 2022. Nevertheless, there are 365 other studies actively looking for volunteers right now."

Answered by AI

What are the intended outcomes of this trial?

"This 21-month medical trial is designed to assess the self-reported sense of community among participants. To evaluate self-management, Coping and Stress Reduction subscales of SUPPH-29 will be utilized; this measure gauges one's confidence in managing their illness through different techniques with ratings ranging from 1 (very little) to 5 (quite a lot). The Patient Health Engagement Measure taps into patients' emotional state when dealing with their condition while also providing scores between 1 and 4 showing how positive/optimistic they are feeling. Finally, electronic health records provide data on number of preventive care/screenings conducted over the duration of the"

Answered by AI
~9 spots leftby Apr 2025